<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Gianluca Gaïdano, Andrea Piccin et al.|Haematologica|2019Cited by 137
Precision Medicine Management of Chronic Lymphocytic LeukemiaRiccardo Moia, Gianluca Gaïdano, Andrea Patriarca et al.|Cancers|2020Cited by 38
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Riccardo Moia, Donatella Talotta et al.|British Journal of Haematology|2022Cited by 24
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levelsRiccardo Moia, Robin Foà, Donatella Talotta et al.|Blood Advances|2025Cited by 17
An update on: molecular genetics of high-risk chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Andrea Patriarca et al.|Expert Review of Hematology|2019Cited by 10